Bart Filius
Direktör/Styrelseledamot på
PROQR THERAPEUTICS N.V.
Förmögenhet: 246 297 $ per 2026-05-31
Profil
Bart Filius is currently Director at Alfasigma UK Ltd., Independent Director at Idorsia Pharmaceuticals Ltd., and Independent Member of the Supervisory Board at ProQR Therapeutics NV since 2019.
Former roles include Non-Executive Director at Idorsia Ltd. from 2024 to 2026, President, Chief Operating & Financial Officer at Lakefront Biotherapeutics from 2021 to 2023, Chief Financial Officer & Country Manager at sanofi-aventis Netherlands BV from 2005 to 2012, and Chief Financial Officer at Sanofi European Treasury Center SA from 2012 to 2014.
Education includes an undergraduate degree from Nyenrode Business Universiteit in 1991 and an MBA from INSEAD in 1996.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
IDORSIA LTD. 0,02 % | 2024-12-31 | 43 091 ( 0,02 % ) | 246 297 $ | 2026-05-31 |
| 2026-03-18 | 0 ( -.--% ) | - $ | 2026-05-31 |
Aktiva positioner av Bart Filius
| Företag | Position | Start |
|---|---|---|
| PROQR THERAPEUTICS N.V. | Direktör/Styrelseledamot | 2019-05-21 |
Galapagos Biotech Ltd.
 Galapagos Biotech Ltd. BiotechnologyHealth Technology Operates as a drug discovery company which provides discovery technologies and services | Direktör/Styrelseledamot | - |
Idorsia Pharmaceuticals Ltd.
 Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Bart Filius
| Företag | Position | Slut |
|---|---|---|
| IDORSIA LTD | Direktör/Styrelseledamot | 2026-05-06 |
| LAKEFRONT BIOTHERAPEUTICS NV | President | 2023-06-30 |
Sanofi European Treasury Center SA
 Sanofi European Treasury Center SA Financial ConglomeratesFinance Provides financial services | Finansdirektör/CFO | 2014-12-01 |
sanofi-aventis Netherlands BV | Finansdirektör/CFO | 2012-03-01 |
Bart Filiuss utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
68
Första gradens relationer
9
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
Galapagos NV
 Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
Nyenrode Business Universiteit
 Nyenrode Business Universiteit Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Galapagos Biotech Ltd.
Galapagos Biotech Ltd. BiotechnologyHealth Technology Operates as a drug discovery company which provides discovery technologies and services | Health Technology |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
sanofi-aventis Netherlands BV | |
Sanofi European Treasury Center SA
Sanofi European Treasury Center SA Financial ConglomeratesFinance Provides financial services | Finance |
ProQR Therapeutics NV
 ProQR Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company with interest in the discovery and development of therapeutics for the treatment of genetic disorders | Health Technology |
Idorsia Ltd.
 Idorsia Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of medicines for unmet medical needs | Health Technology |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals | Health Technology |
